The Battle Over Injecting Hepatitis B Vaccine Into Babies on the First Day After Birth
Last week, a very public battle over the wisdom of the at-birth hepatitis B vaccination policy started playing out at a Sept. 18-19, 2025 meeting of U.S. Centers for Disease Control (CDC) when a majority of the newly appointed members of the CDC’s Advisory Committee on Immunization Practices (ACIP)1 went head to head with pharmaceutical […]
Nine States Unite in Northeast to Challenge CDC’s New Vaccine Use Recommendations
In response to recent changes made to vaccine use recommendations issued by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC), nine northeastern states and New York City have formally established the Northeast Public Health Collaborative, a regional partnership they say is intended to improve coordination of […]
FDA to Release Report on Child Deaths After COVID Shots
On Sept. 4, 2025, the commissioner of the U.S. Food and Drug Administration (FDA), Marty Makary, MD, announced the agency will release a detailed report investigating deaths among children following receipt of COVID-19 shots.1 2 Dr. Makary stated that officials have begun carrying out an “intensive investigation” into reports submitted to the Vaccine Adverse Event […]
CDC’s ACIP: The Next Generation
On Sept. 15, 2025, the U.S. Department of Health and Human Services (DHHS) announced the appointment of five additional members to the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP). The new members—Catherine Stein, PhD; Evelyn Griffin, MD; Hillary Blackburn, PharmD, MBA; Kirk Milhoan; MD, PhD; and Raymond Pollak, MD—bring […]
COVID-19 Shots Associated with Neuropsychiatric Disorders
A 2025 study published in the International Journal of Innovative Research in Medical Science examined whether mRNA COVID-19 shots are linked to neuropsychiatric conditions, raising questions about their potential to damage the brain and mental health. The researchers, most of which are affiliated with The Wellness Company and the McCullough Foundation, note that the mRNA […]
FDA Suspends Chikungunya Vaccine Over Safety Concerns
The U.S. Food and Drug Administration (FDA) announced on Aug. 22, 2025 that it has suspended the license for French drugmaker Valneva’s chikungunya vaccine, warning that its continued use “poses a danger to public health” following a risk–benefit analysis conducted by the agency’s Center for Biologics Evaluation and Research (CBER). The decision came after reports […]